---
title: "Teprotumumab Effects on Thyroid Eye Disease in a Prospective Japanese Cohort: MRI-Based Comparison with Intravenous Glucocorticoid Therapy"
id: "medrxiv-4-teprotumumab-effects-on-thyroid-eye-disease-in-a-prospective-japanese-cohort"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-4-teprotumumab-effects-on-thyroid-eye-disease-in-a-prospective-japanese-cohort"
content_type: "clinical_feed_article"
specialty: "Research Highlights"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.07.26357453v1?rss=1"
published_at: "2026-07-09T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Teprotumumab Effects on Thyroid Eye Disease in a Prospective Japanese Cohort: MRI-Based Comparison with Intravenous Glucocorticoid Therapy
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-4-teprotumumab-effects-on-thyroid-eye-disease-in-a-prospective-japanese-cohort
- **Specialty:** [Research Highlights](https://medichelpline.com/clinical-feed/research-highlights.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.07.26357453v1?rss=1)
- **Published At:** 2026-07-09T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
Context. Teprotumumab (TEP) is an emerging treatment for thyroid eye disease (TED), but real-world evidence outside the United States remains limited, and detailed changes in orbital components have not been fully clarified. Objective. To evaluate the effectiveness of TEP based on clinical manifestations and magnetic resonance imaging (MRI) findings, and compare it with that of intravenous glucocorticoid (IVGC) therapy. Methods: The TEP cohort included all 18 patients who started TEP therapy at Kyoto University Hospital by July 31, 2025. A historical IVGC cohort included 20 patients matched to the TEP cohort. Results: During 24 weeks of TEP therapy, proptosis measured using a Hertel exophthalmometer improved from 22 (20-22) to 19 (16-21) mm (p = 0.025), and clinical activity score decreased from 4 (3-5) to 1 (0-1) point (p < 0.001). Among 15 patients with diplopia, a reduction of at least 1 point in Gorman score was observed in 9 patients (60.0%). Thyroid-stimulating antibody titers decreased from 1,180% (349-4,710) to 282% (132-504) (p = 0.013).
## Clinical Analysis & Structured Key Points
medRxiv (Clinical Preprints) published a clinical update in Research Highlights on 09 Jul 2026. The item focuses on Teprotumumab Effects on Thyroid Eye Disease in a Prospective Japanese Cohort: MRI-Based Comparison with Intravenous Glucocorticoid Therapy. Review the original article for the full source wording and details.
## Related Clinical Research

- [Modelling the impact of mosquito bed net utilization on malaria transmission and evolution of pyrethroid resistance](https://medichelpline.com/clinical-feed/plos-one-23-modelling-the-impact-of-mosquito-bed-net-utilization-on-malaria-transmission.md)
- [Maternal knowledge of obstetric danger signs and related factors among antenatal care attendees in Hargeisa, Somaliland: A cross-sectional analysis](https://medichelpline.com/clinical-feed/plos-one-7-maternal-knowledge-of-obstetric-danger-signs-and-related-factors-among.md)
- [Self-explaining artificial intelligence for the classification of B cell non-Hodgkin lymphoma: A diagnostic decision support study](https://medichelpline.com/clinical-feed/plos-medicine-0-self-explaining-artificial-intelligence-for-the-classification-of-b-cell-non.md)
- [New study maps how 12 modifiable dementia risks differ around the world](https://medichelpline.com/clinical-feed/medical-news-today-0-new-study-maps-how-12-modifiable-dementia-risks-differ-around-the-world.md)
- [Eating an avocado a day may lower cholesterol in adults with obesity](https://medichelpline.com/clinical-feed/medical-news-today-1-eating-an-avocado-a-day-may-lower-cholesterol-in-adults-with-obesity.md)

## Navigation
- [← Back to Research Highlights Feed](https://medichelpline.com/clinical-feed/research-highlights.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.